GRAYBUG
GrayBug is a pharmaceutical company that focuses on developing the next generation of products for the treatment of chronic vision-threatening diseases of the retina and optic nerve. The company is currently developing a continuum of proprietary micro – and nanoparticle controlled release technologies and implants for strategic partnership and its own therapeutic products for major ocular disease indications including wet AMD and Glaucoma. The company was founded in 2011 and headquartered in Baltimore, Maryland.
GRAYBUG
Social Links:
Industry:
Biotechnology Health Care Medical Wellness
Founded:
2011-01-01
Address:
Baltimore, Maryland, United States
Country:
United States
Website Url:
http://www.graybug.vision
Total Employee:
51+
Status:
Active
Contact:
650-487-2800
Email Addresses:
[email protected]
Total Funding:
129.24 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail GoDaddy DNS Google Google Cloud Pound Sterling Japanese Yen WP Engine
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
CEL-SCI
CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.
Edison Pharmaceuticals
Edison Pharmaceuticals develops medicines for the treatments of children and adults diagnosed with rare and neglected diseases.
ORIG3N
ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
OrbiMed
OrbiMed investment in Series C - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series C - GrayBug
Deerfield Capital Management
Deerfield Capital Management investment in Series C - GrayBug
C-Bridge Capital
C-Bridge Capital investment in Series C - GrayBug
Clarus Ventures
Clarus Ventures investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series B - GrayBug
OrbiMed
OrbiMed investment in Series B - GrayBug
Deerfield
Deerfield investment in Series B - GrayBug
Hatteras Venture Partners
Hatteras Venture Partners investment in Series A - GrayBug
Maryland Venture Fund
Maryland Venture Fund investment in Series A - GrayBug
Official Site Inspections
http://www.graybug.vision
- Host name: 199.59.243.226
- IP address: 199.59.243.226
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
